Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Colonic epithelial sodium and short-chain fatty acid (SCFA) transport pathways are integrated systems responsible for maintaining fluid balance and providing energy to the colonic mucosa. Sodium absorption is primarily mediated by the epithelial sodium channel (ENaC) and the sodium-hydrogen exchanger 3 (NHE3), which are critical for water reabsorption and systemic blood pressure regulation (PubMed: 25644341). SCFAs, including butyrate and acetate, are transported via monocarboxylate transporters such as MCT1 and the sodium-coupled SMCT1 (SLC5A8) (UniProt: Q8N695). These pathways are functionally linked, as SCFA absorption often enhances sodium and water uptake, a process vital for preventing dehydration (PubMed: 16368716). Dysregulation of these transporters is a hallmark of inflammatory bowel diseases (IBD) and diarrheal disorders, where impaired absorption leads to electrolyte loss and mucosal damage (PubMed: 21903767). Pharmacological agents like tenapanor target NHE3 to treat irritable bowel syndrome, while ENaC inhibitors like amiloride are used for hypertension (StatPearls: NBK554444). Furthermore, therapeutic strategies often involve increasing SCFA availability to support colonocyte health and reduce inflammation in ulcerative colitis. Understanding these pathways is essential for developing targeted treatments for gastrointestinal and cardiovascular conditions.
Modulation of ion and metabolite flux across the colonic epithelium to regulate fluid volume, maintain mucosal integrity, and provide metabolic fuel for colonocytes.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonic epithelial sodium and short-chain fatty acid (SCFA) transport pathways.